A KRAS wild type mutational status confers a survival advantage in pancreatic ductal adenocarcinoma – PubMed
Similar to previously reported studies, PDAC with a KRAS wild type mutational profile has a better prognosis with a longer OS. This improved prognosis is independent of the protocol utilized in therapy for these patients. Our findings suggest that future clinical trials in pancreatic cancer s …